Micah Thompson
Family Medicine · Terre Haute, INNPI 1821108838
Payments from drug & device makers
Across 160 payments — averaging $16.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$392
- AstraZeneca$361
- Amgen$319
- Novartis$258
- Novo Nordisk$212
- Pfizer$97
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,660100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 21 | $392 |
| AstraZeneca | 18 | $361 |
| Amgen | 20 | $319 |
| Novartis | 15 | $258 |
| Novo Nordisk | 18 | $212 |
| Pfizer | 7 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $96 |
| GSK | 6 | $91 |
| Exact Sciences | 5 | $91 |
| Dexcom, Inc. | 4 | $89 |
| Lilly USA, LLC | 4 | $58 |
| Bayer | 3 | $48 |
| Phathom Pharmaceuticals, Inc. | 3 | $45 |
| Sanofi-aventis U.S. LLC | 3 | $44 |
| Boehringer Ingelheim | 3 | $43 |
| Daiichi Sankyo Inc. | 2 | $42 |
| Sanofi Pasteur Inc. | 2 | $41 |
| Astellas Pharma US Inc | 2 | $41 |
| E.r. Squibb & Sons, L.L.C. | 2 | $37 |
| Mylan Specialty L.p. | 2 | $34 |
| Amneal Pharmaceuticals LLC | 2 | $28 |
| Amarin Pharma, Inc. | 2 | $27 |
| Biohaven Pharmaceuticals, Inc. | 2 | $25 |
| Shield Therapeutics Inc | 1 | $22 |
| Itamar Medical Inc | 1 | $22 |
| Neos Therapeutics, LP | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Merck | 1 | $17 |
| Radius Health, Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $11 |
How this compares
$2,660 in reported general payments places this provider in the 75th percentile of 2,709 family medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 134 | $133,927 |
| MounjaroTirzepatide | 85 | $97,960 |
| OzempicSemaglutide | 85 | $95,105 |
| XareltoRivaroxaban | 34 | $46,662 |
| JanuviaSitagliptin Phosphate | 53 | $44,468 |
| EliquisApixaban | 65 | $41,650 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 35 | $38,555 |
| RybelsusSemaglutide | 20 | $34,640 |
| TrulicityDulaglutide | 15 | $22,681 |
| Tresiba Flextouch U-100Insulin Degludec | 32 | $20,026 |
| MyrbetriqMirabegron | 19 | $15,672 |
| Repatha SureclickEvolocumab | 17 | $15,074 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 22 | $12,113 |
| Breo ElliptaFluticasone/Vilanterol | 18 | $10,401 |
| Repatha SyringeEvolocumab | 11 | $7,448 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $43 | $133,927134 claims |
| Novo NordiskOzempic, Rybelsus | $212 | $129,745105 claims |
| Lilly USA, LLCMounjaro, Trulicity | $58 | $120,641100 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Shingrix | $91 | $51,42366 claims |
| Johnson & JohnsonXarelto | $11 | $46,66234 claims |
| MerckJanuvia | $17 | $44,46853 claims |
| PfizerEliquis | $97 | $41,65065 claims |
| Astellas Pharma US IncMyrbetriq | $41 | $15,67219 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $28 | $3,555369 claims |
| AbbVieSynthroid | $392 | $2,94745 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,709 family medicine providers in Indiana.
Other family medicine in Terre Haute
- Blair BrengleIndianapolis$10.6M
- Laura HelmanMishawaka$4M
- J Christopher SartoreEvansville$3.9M
- Hubert ReyesEvansville$3.2M
- David SchultzEvansville$3M
- Steven SmithIndianapolis$2.5M
- Renee Michelle GalenNewburgh$2.1M
- Eric HewittAvon$1.7M
- Alexander Dela LlanaEvansville$1.6M
- Jonathan ConditMuncie$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.